Skip to content
10-Q

Quarterly Report

ALPINE IMMUNE SCIENCES, INC.

0001626199-23-000088

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 49.2M sh
Shares Diluted Q2 2023 · Jun 30, 2023 48.05M sh
Shares Diluted Q2 2023 · Jun 30, 2023 47.81M sh
Shares Diluted Q2 2023 · Jun 30, 2022 30.32M sh
Shares Diluted Q2 2023 · Jun 30, 2022 30.31M sh
Capex Q2 2023 · Jun 30, 2023 $372K
Capex Q2 2023 · Jun 30, 2022 $241K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$44.24M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$10.62M
Short Term Debt Q2 2023 · Jun 30, 2023 $0
Short Term Debt Q2 2023 · Dec 31, 2022 $3.38M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $34.08M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $13.38M
Stockholders Equity Q2 2023 · Jun 30, 2023 $169.39M
Stockholders Equity Q2 2023 · Mar 31, 2023 $169.54M
Stockholders Equity Q2 2023 · Dec 31, 2022 $179.42M
Stockholders Equity Q2 2023 · Jun 30, 2022 $99.54M
Stockholders Equity Q2 2023 · Mar 31, 2022 $115.43M
Stockholders Equity Q2 2023 · Dec 31, 2021 $120.9M
Current Liabilities Q2 2023 · Jun 30, 2023 $53.41M
Current Liabilities Q2 2023 · Dec 31, 2022 $58M
Total Liabilities Q2 2023 · Jun 30, 2023 $83.45M
Total Liabilities Q2 2023 · Dec 31, 2022 $107.27M
Current Assets Q2 2023 · Jun 30, 2023 $207.32M
Current Assets Q2 2023 · Dec 31, 2022 $240.99M
Total Assets Q2 2023 · Jun 30, 2023 $252.84M
Total Assets Q2 2023 · Dec 31, 2022 $286.69M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.27
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.55
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.60
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.85
Eps Basic Q2 2023 · Jun 30, 2023 −$0.27
Eps Basic Q2 2023 · Jun 30, 2023 −$0.55
Eps Basic Q2 2023 · Jun 30, 2022 −$0.60
Eps Basic Q2 2023 · Jun 30, 2022 −$0.85
Sga Expense Q2 2023 · Jun 30, 2023 $5.01M
Sga Expense Q2 2023 · Jun 30, 2023 $10.41M
Sga Expense Q2 2023 · Jun 30, 2022 $4.19M
Sga Expense Q2 2023 · Jun 30, 2022 $8.97M
Rd Expense Q2 2023 · Jun 30, 2023 $19.24M
Rd Expense Q2 2023 · Jun 30, 2023 $38.82M
Rd Expense Q2 2023 · Jun 30, 2022 $17.59M
Rd Expense Q2 2023 · Jun 30, 2022 $33.9M
Net Income Q2 2023 · Jun 30, 2023 −$13.16M
Net Income Q2 2023 · Jun 30, 2023 −$26.42M
Net Income Q2 2023 · Mar 31, 2023 −$13.27M
Net Income Q2 2023 · Jun 30, 2022 −$18.1M
Net Income Q2 2023 · Jun 30, 2022 −$25.63M
Net Income Q2 2023 · Mar 31, 2022 −$7.53M
Operating Income Q2 2023 · Jun 30, 2023 −$15.66M
Operating Income Q2 2023 · Jun 30, 2023 −$31.25M
Operating Income Q2 2023 · Jun 30, 2022 −$16.49M
Operating Income Q2 2023 · Jun 30, 2022 −$23.95M
Revenue Q2 2023 · Jun 30, 2023 $8.59M
Revenue Q2 2023 · Jun 30, 2023 $17.98M
Revenue Q2 2023 · Jun 30, 2022 $5.29M
Revenue Q2 2023 · Jun 30, 2022 $18.92M